Amyris, Inc. (NASDAQ:AMRS) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition.
Amyris, Inc. (NASDAQ:AMRS) Files An 8-K Results of Operations and Financial Condition
On March 12, 2020, Amyris, Inc. (the “Company”) issued a press release announcing the Company’s financial results for its fiscal quarter and year ended December 31, 2019. A copy of this press release, entitled “Amyris Reports Another Strong Quarter of Recurring Revenue Growth,” is furnished as Exhibit 99.1>to this Current Report on Form 8-K and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
The following exhibit is furnished herewith:
The information in this report, including the exhibit hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference in such filing.
AMYRIS, INC. Exhibit
EX-99.1 2 exhibit_991.htm EXHIBIT 99.1 Exhibit Exhibit 99.1 Amyris Reports Another Strong Quarter of Recurring Revenue Growth •Fourth quarter total revenue of $40.5 million increased 148% over Fourth Quarter 2018•Fiscal 2019 total revenue of $152.6 million increased 140% over Fiscal 2018•More than doubled recurring revenue year over year with gross margin of 56%EMERYVILLE,…
To view the full exhibit click
EX-99.1 2 exhibit_991.htm EXHIBIT 99.1 Exhibit Exhibit 99.1 Amyris Reports Another Strong Quarter of Recurring Revenue Growth •Fourth quarter total revenue of $40.5 million increased 148% over Fourth Quarter 2018•Fiscal 2019 total revenue of $152.6 million increased 140% over Fiscal 2018•More than doubled recurring revenue year over year with gross margin of 56%EMERYVILLE,…
To view the full exhibit click
hereAbout Amyris, Inc. (NASDAQ:AMRS)
Amyris, Inc. is an integrated industrial biotechnology company. The Company is engaged in research and development and sales of fuels and farnesene-derived products. It is applying its industrial synthetic biology platform to engineer, manufacture and sell products into a range of consumer and industrial markets, including cosmetics, flavors and fragrances (F&F), solvents and cleaners, polymers, lubricants, healthcare products and fuels. The Company focuses on a renewable hydrocarbon molecule called farnesene (Biofene). The Company is expanding its range of products across various categories divided into consumer and industrial applications. For consumer applications, the Company is developing and selling personal care products (which include ingredients for cosmetics and F&F), healthcare products and formulated end user products, such as Biossance brand skincare products and Muck Daddy brand hand cleaner product.
